A detailed history of Pingora Partners LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Pingora Partners LLC holds 2,640 shares of ABBV stock, worth $453,367. This represents 0.37% of its overall portfolio holdings.

Number of Shares
2,640
Previous 2,640 -0.0%
Holding current value
$453,367
Previous $453 Million 15.14%
% of portfolio
0.37%
Previous 0.32%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$159.82 - $182.1 $190,185 - $216,699
1,190 Added 82.07%
2,640 $481 Million
Q4 2023

Feb 12, 2024

BUY
$137.6 - $154.97 $199,520 - $224,706
1,450 New
1,450 $225 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $304B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Pingora Partners LLC Portfolio

Follow Pingora Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pingora Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pingora Partners LLC with notifications on news.